Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ocular Changes After Selective Alpha-2 Receptor Agonist.

NCT05670015 is registered in ClinicalTrials.gov with Benha University as lead sponsor.

NCT NCT05670015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05670015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ocular Changes After Selective Alpha-2 Receptor Agonist.
Lead sponsor
Benha University
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2023
Completion date
September 22, 2023
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aberration, corneal wavefront, glaucoma, suspect